Kestra Advisory Services LLC boosted its holdings in shares of The Cooper Companies, Inc. (NYSE:COO) by 35.2% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,156 shares of the medical device company’s stock after acquiring an additional 301 shares during the quarter. Kestra Advisory Services LLC’s holdings in The Cooper Companies were worth $444,000 as of its most recent SEC filing.
A number of other institutional investors have also made changes to their positions in the business. Price T Rowe Associates Inc. MD increased its position in shares of The Cooper Companies by 1.3% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 3,949,277 shares of the medical device company’s stock worth $1,434,851,000 after acquiring an additional 51,134 shares during the period. Janus Henderson Group PLC increased its holdings in The Cooper Companies by 0.4% during the 4th quarter. Janus Henderson Group PLC now owns 2,155,648 shares of the medical device company’s stock worth $783,196,000 after purchasing an additional 9,390 shares during the period. Victory Capital Management Inc. raised its position in The Cooper Companies by 4.0% during the 1st quarter. Victory Capital Management Inc. now owns 749,389 shares of the medical device company’s stock valued at $287,833,000 after purchasing an additional 28,933 shares in the last quarter. Bessemer Group Inc. lifted its holdings in shares of The Cooper Companies by 1.2% in the 4th quarter. Bessemer Group Inc. now owns 636,784 shares of the medical device company’s stock worth $231,357,000 after buying an additional 7,858 shares during the period. Finally, Norges Bank bought a new position in shares of The Cooper Companies during the 4th quarter worth $175,360,000. 97.41% of the stock is currently owned by institutional investors.
Shares of NYSE:COO opened at $374.12 on Friday. The company has a quick ratio of 0.75, a current ratio of 1.33 and a debt-to-equity ratio of 0.21. The firm has a market cap of $18.42 billion, a price-to-earnings ratio of 7.89, a P/E/G ratio of 2.81 and a beta of 0.82. The company’s 50-day simple moving average is $393.29. The Cooper Companies, Inc. has a 1 year low of $268.92 and a 1 year high of $415.96.
In other news, SVP Agostino Ricupati sold 2,643 shares of The Cooper Companies stock in a transaction on Thursday, April 15th. The shares were sold at an average price of $397.92, for a total transaction of $1,051,702.56. Following the completion of the sale, the senior vice president now directly owns 2,709 shares in the company, valued at $1,077,965.28. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 1.70% of the company’s stock.
Several analysts recently weighed in on the company. Redburn Partners assumed coverage on The Cooper Companies in a report on Friday, April 23rd. They issued a “buy” rating for the company. Raymond James increased their price objective on shares of The Cooper Companies from $375.00 to $415.00 and gave the company an “outperform” rating in a research note on Friday, March 5th. KeyCorp lifted their price objective on shares of The Cooper Companies from $429.00 to $444.00 and gave the company an “overweight” rating in a report on Wednesday, April 28th. They noted that the move was a valuation call. Piper Sandler boosted their price objective on shares of The Cooper Companies from $435.00 to $440.00 and gave the stock an “overweight” rating in a research note on Tuesday, June 1st. Finally, Jefferies Financial Group reaffirmed a “buy” rating and set a $450.00 target price on shares of The Cooper Companies in a research report on Monday, May 24th. Four analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $388.38.
The Cooper Companies Company Profile
The Cooper Companies, Inc operates as a medical device company worldwide. It operates through two segments, CooperVision and CooperSurgical. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.
Featured Article: Trading Halts Explained
Receive News & Ratings for The Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.